Loading…
Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma
Saved in:
| Published in: | Endocrine 2018-07, Vol.61 (1), p.169-172 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c415t-b546abfd472e3a563f23d73a52e75e47c9505f4acf186ca5a473f5c3b2be2c4b3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c415t-b546abfd472e3a563f23d73a52e75e47c9505f4acf186ca5a473f5c3b2be2c4b3 |
| container_end_page | 172 |
| container_issue | 1 |
| container_start_page | 169 |
| container_title | Endocrine |
| container_volume | 61 |
| creator | Claps, Mélanie Cerri, Sara Grisanti, Salvatore Lazzari, Barbara Ferrari, Vittorio Roca, Elisa Perotti, Paola Terzolo, Massimo Sigala, Sandra Berruti, Alfredo |
| description | |
| doi_str_mv | 10.1007/s12020-017-1428-9 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1950177700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2054144999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-b546abfd472e3a563f23d73a52e75e47c9505f4acf186ca5a473f5c3b2be2c4b3</originalsourceid><addsrcrecordid>eNp1kc1KxDAUhYMo_j-AGwm4cVO9SZNmupTBPxDcKLgLaXLrVNpmTFphdr6Gr-eTmHH8AcFVDvd-5yThEHLA4IQBqNPIOHDIgKmMCT7JyjWyzaQs0wRgPelcygxg8rBFdmJ8AuCcF2qTbPESWAkF3ybPZ841_SPtcFgEM_c90sFTO8PODzNMkwWdt2OkXTP4waRt7QOdjnGWTO-vb5HGRe-C75C68dNq3IvpLbokAvbe-jA01rTUmmCb3ndmj2zUpo24_3XukvuL87vpVXZze3k9PbvJrGByyCopClPVTiiOuZFFXvPcqaQ4KolC2VKCrIWxNZsU1kgjVF5Lm1e8Qm5Fle-S41XuPPjnEeOguyZabNv0Cz9GzVIAU0oBJPToD_rkx9Cn12kOUjAhyrJMFFtRNvgYA9Z6HprOhIVmoJd96FUfOsXqZR966Tn8Sh6rDt2P47uABPAVENOqf8Twe_X_qR_RUJg1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2054144999</pqid></control><display><type>article</type><title>Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma</title><source>Springer Nature</source><creator>Claps, Mélanie ; Cerri, Sara ; Grisanti, Salvatore ; Lazzari, Barbara ; Ferrari, Vittorio ; Roca, Elisa ; Perotti, Paola ; Terzolo, Massimo ; Sigala, Sandra ; Berruti, Alfredo</creator><creatorcontrib>Claps, Mélanie ; Cerri, Sara ; Grisanti, Salvatore ; Lazzari, Barbara ; Ferrari, Vittorio ; Roca, Elisa ; Perotti, Paola ; Terzolo, Massimo ; Sigala, Sandra ; Berruti, Alfredo</creatorcontrib><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-017-1428-9</identifier><identifier>PMID: 29019062</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adrenal Cortex Neoplasms - complications ; Adrenocortical Carcinoma - complications ; Adrenocorticotropic hormone ; Adult ; Aged ; Antimetabolites, Antineoplastic - therapeutic use ; Antineoplastic Agents, Hormonal - therapeutic use ; Chemotherapy ; Cushing syndrome ; Cushing Syndrome - drug therapy ; Cushing Syndrome - etiology ; Diabetes ; Drug Therapy, Combination ; Endocrinology ; Feasibility Studies ; Humanities and Social Sciences ; Humans ; Hydrocortisone - urine ; Internal Medicine ; Male ; Medicine ; Medicine & Public Health ; Metyrapone - therapeutic use ; Middle Aged ; Mitotane - therapeutic use ; multidisciplinary ; Nervous system diseases ; Pituitary ; Research Letter ; Science ; Treatment Outcome</subject><ispartof>Endocrine, 2018-07, Vol.61 (1), p.169-172</ispartof><rights>Springer Science+Business Media, LLC 2017</rights><rights>Copyright Springer Science & Business Media 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-b546abfd472e3a563f23d73a52e75e47c9505f4acf186ca5a473f5c3b2be2c4b3</citedby><cites>FETCH-LOGICAL-c415t-b546abfd472e3a563f23d73a52e75e47c9505f4acf186ca5a473f5c3b2be2c4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29019062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Claps, Mélanie</creatorcontrib><creatorcontrib>Cerri, Sara</creatorcontrib><creatorcontrib>Grisanti, Salvatore</creatorcontrib><creatorcontrib>Lazzari, Barbara</creatorcontrib><creatorcontrib>Ferrari, Vittorio</creatorcontrib><creatorcontrib>Roca, Elisa</creatorcontrib><creatorcontrib>Perotti, Paola</creatorcontrib><creatorcontrib>Terzolo, Massimo</creatorcontrib><creatorcontrib>Sigala, Sandra</creatorcontrib><creatorcontrib>Berruti, Alfredo</creatorcontrib><title>Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><subject>Adrenal Cortex Neoplasms - complications</subject><subject>Adrenocortical Carcinoma - complications</subject><subject>Adrenocorticotropic hormone</subject><subject>Adult</subject><subject>Aged</subject><subject>Antimetabolites, Antineoplastic - therapeutic use</subject><subject>Antineoplastic Agents, Hormonal - therapeutic use</subject><subject>Chemotherapy</subject><subject>Cushing syndrome</subject><subject>Cushing Syndrome - drug therapy</subject><subject>Cushing Syndrome - etiology</subject><subject>Diabetes</subject><subject>Drug Therapy, Combination</subject><subject>Endocrinology</subject><subject>Feasibility Studies</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hydrocortisone - urine</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metyrapone - therapeutic use</subject><subject>Middle Aged</subject><subject>Mitotane - therapeutic use</subject><subject>multidisciplinary</subject><subject>Nervous system diseases</subject><subject>Pituitary</subject><subject>Research Letter</subject><subject>Science</subject><subject>Treatment Outcome</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kc1KxDAUhYMo_j-AGwm4cVO9SZNmupTBPxDcKLgLaXLrVNpmTFphdr6Gr-eTmHH8AcFVDvd-5yThEHLA4IQBqNPIOHDIgKmMCT7JyjWyzaQs0wRgPelcygxg8rBFdmJ8AuCcF2qTbPESWAkF3ybPZ841_SPtcFgEM_c90sFTO8PODzNMkwWdt2OkXTP4waRt7QOdjnGWTO-vb5HGRe-C75C68dNq3IvpLbokAvbe-jA01rTUmmCb3ndmj2zUpo24_3XukvuL87vpVXZze3k9PbvJrGByyCopClPVTiiOuZFFXvPcqaQ4KolC2VKCrIWxNZsU1kgjVF5Lm1e8Qm5Fle-S41XuPPjnEeOguyZabNv0Cz9GzVIAU0oBJPToD_rkx9Cn12kOUjAhyrJMFFtRNvgYA9Z6HprOhIVmoJd96FUfOsXqZR966Tn8Sh6rDt2P47uABPAVENOqf8Twe_X_qR_RUJg1</recordid><startdate>20180701</startdate><enddate>20180701</enddate><creator>Claps, Mélanie</creator><creator>Cerri, Sara</creator><creator>Grisanti, Salvatore</creator><creator>Lazzari, Barbara</creator><creator>Ferrari, Vittorio</creator><creator>Roca, Elisa</creator><creator>Perotti, Paola</creator><creator>Terzolo, Massimo</creator><creator>Sigala, Sandra</creator><creator>Berruti, Alfredo</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180701</creationdate><title>Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma</title><author>Claps, Mélanie ; Cerri, Sara ; Grisanti, Salvatore ; Lazzari, Barbara ; Ferrari, Vittorio ; Roca, Elisa ; Perotti, Paola ; Terzolo, Massimo ; Sigala, Sandra ; Berruti, Alfredo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-b546abfd472e3a563f23d73a52e75e47c9505f4acf186ca5a473f5c3b2be2c4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adrenal Cortex Neoplasms - complications</topic><topic>Adrenocortical Carcinoma - complications</topic><topic>Adrenocorticotropic hormone</topic><topic>Adult</topic><topic>Aged</topic><topic>Antimetabolites, Antineoplastic - therapeutic use</topic><topic>Antineoplastic Agents, Hormonal - therapeutic use</topic><topic>Chemotherapy</topic><topic>Cushing syndrome</topic><topic>Cushing Syndrome - drug therapy</topic><topic>Cushing Syndrome - etiology</topic><topic>Diabetes</topic><topic>Drug Therapy, Combination</topic><topic>Endocrinology</topic><topic>Feasibility Studies</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hydrocortisone - urine</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metyrapone - therapeutic use</topic><topic>Middle Aged</topic><topic>Mitotane - therapeutic use</topic><topic>multidisciplinary</topic><topic>Nervous system diseases</topic><topic>Pituitary</topic><topic>Research Letter</topic><topic>Science</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Claps, Mélanie</creatorcontrib><creatorcontrib>Cerri, Sara</creatorcontrib><creatorcontrib>Grisanti, Salvatore</creatorcontrib><creatorcontrib>Lazzari, Barbara</creatorcontrib><creatorcontrib>Ferrari, Vittorio</creatorcontrib><creatorcontrib>Roca, Elisa</creatorcontrib><creatorcontrib>Perotti, Paola</creatorcontrib><creatorcontrib>Terzolo, Massimo</creatorcontrib><creatorcontrib>Sigala, Sandra</creatorcontrib><creatorcontrib>Berruti, Alfredo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Claps, Mélanie</au><au>Cerri, Sara</au><au>Grisanti, Salvatore</au><au>Lazzari, Barbara</au><au>Ferrari, Vittorio</au><au>Roca, Elisa</au><au>Perotti, Paola</au><au>Terzolo, Massimo</au><au>Sigala, Sandra</au><au>Berruti, Alfredo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2018-07-01</date><risdate>2018</risdate><volume>61</volume><issue>1</issue><spage>169</spage><epage>172</epage><pages>169-172</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><cop>New York</cop><pub>Springer US</pub><pmid>29019062</pmid><doi>10.1007/s12020-017-1428-9</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1355-008X |
| ispartof | Endocrine, 2018-07, Vol.61 (1), p.169-172 |
| issn | 1355-008X 1559-0100 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1950177700 |
| source | Springer Nature |
| subjects | Adrenal Cortex Neoplasms - complications Adrenocortical Carcinoma - complications Adrenocorticotropic hormone Adult Aged Antimetabolites, Antineoplastic - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Chemotherapy Cushing syndrome Cushing Syndrome - drug therapy Cushing Syndrome - etiology Diabetes Drug Therapy, Combination Endocrinology Feasibility Studies Humanities and Social Sciences Humans Hydrocortisone - urine Internal Medicine Male Medicine Medicine & Public Health Metyrapone - therapeutic use Middle Aged Mitotane - therapeutic use multidisciplinary Nervous system diseases Pituitary Research Letter Science Treatment Outcome |
| title | Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A51%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adding%20metyrapone%20to%20chemotherapy%20plus%20mitotane%20for%20Cushing%E2%80%99s%20syndrome%20due%20to%20advanced%20adrenocortical%20carcinoma&rft.jtitle=Endocrine&rft.au=Claps,%20M%C3%A9lanie&rft.date=2018-07-01&rft.volume=61&rft.issue=1&rft.spage=169&rft.epage=172&rft.pages=169-172&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-017-1428-9&rft_dat=%3Cproquest_cross%3E2054144999%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-b546abfd472e3a563f23d73a52e75e47c9505f4acf186ca5a473f5c3b2be2c4b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2054144999&rft_id=info:pmid/29019062&rfr_iscdi=true |